Figures & data
Table 1. Characteristics of studies evaluating the effects of AT1R A1166C gene polymorphism on ESRD risk.
Table 2. Meta-analysis of the association of AT1R A1166C gene polymorphism with ESRD risk.
Table 3. Characteristics of univariate meta-regression analysis.
Coll E, Campos B, Nunez DG, et al. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency. J Nephrol. 2003;16:357–364 Lee KB, Kim UK. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD. Yonsei Med J. 2003;44:641–647 Chang HR, Cheng CH, Shu KH, et al. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc. 2003;66:51–56 Lau YK, Woo KT, Choong HL, et al. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephrol Physiol. 2004;97:1–8 Buraczynska M, Ksiazek P, Drop A, et al. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant. 2006;21:979–983 Papp F, Friedman AL, Bereczki C, et al. Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr Nephrol. 2003;18:150–154 Huang HD, Lin FJ, Li XJ, et al. Genetic polymorphisms of the renin–angiotensin–aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. Chin Med J. 2010;123:3238–3242 Zsom M, Fulop T, Zsom L, et al. Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial Int. 2011;15:501–508